← 返回

通过微创干预改造肿瘤免疫微环境

英文原题:Engineering the Tumor Immune Microenvironment through Minimally Invasive Interventions.

查看英文原题

Engineering the Tumor Immune Microenvironment through Minimally Invasive Interventions.

PubMed 2022/12/29(内容时间) Cancers (Basel) Q2 · IF 4.8(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

中文摘要

肿瘤微环境(TME)具有独特特征,会对抗癌治疗形成多种物理、生化和免疫屏障。快速发展的免疫工程领域为通过有效破坏肿瘤来解除肿瘤免疫微环境的抑制提供了新机会。此类治疗经全身给药时,局部作用往往有限,并可能造成全身毒性和肿瘤耐药等非靶部位不良影响。介入放射科医生可利用现代影像引导技术在局部递送治疗,以调节免疫抑制性TME、加速肿瘤细胞死亡并增强抗肿瘤应答。局部治疗包括瘤内给药、纳米机器人、纳米颗粒和可植入微型装置;可用于局部破坏肿瘤的物理疗法还包括光动力治疗、电穿孔、热疗、冷疗、超声治疗、组织消融和放疗。尽管介入医生只能在局部调节TME,免疫应答仍可在身体其他部位被动员,这称为远隔效应,可带来更广泛的下游抗肿瘤作用。局部递送现代免疫工程疗法(如局部区域CAR-T 治疗)并联合免疫检查点抑制剂,可有效调节免疫抑制性TME。本文从微创治疗角度综述当前改变TME并革新肿瘤学的多种进展和技术。

展开英文摘要原文

The tumor microenvironment (TME) is a unique landscape that poses several physical, biochemical, and immune barriers to anti-cancer therapies. The rapidly evolving field of immuno-engineering provides new opportunities to dismantle the tumor immune microenvironment by efficient tumor destruction. Systemic delivery of such treatments can often have limited local effects, leading to unwanted offsite effects such as systemic toxicity and tumor resistance. Interventional radiologists use contemporary image-guided techniques to locally deliver these therapies to modulate the immunosuppressive TME, further accelerating tumor death and invoking a better anti-tumor response. These involve local therapies such as intratumoral drug delivery, nanorobots, nanoparticles, and implantable microdevices.

Physical therapies such as photodynamic therapy, electroporation, hyperthermia, hypothermia, ultrasound therapy, histotripsy, and radiotherapy are also available for local tumor destruction. While the interventional radiologist can only locally manipulate the TME, there are systemic offsite recruitments of the immune response. This is known as the abscopal effect, which leads to more significant anti-tumoral downstream effects.

Local delivery of modern immunoengineering methods such as locoregional CAR-T therapy combined with immune checkpoint inhibitors efficaciously modulates the immunosuppressive TME. This review highlights the various advances and technologies available now to change the TME and revolutionize oncology from a minimally invasive viewpoint.

论文信息

作者
Pal K、Sheth RA
单位
Department of Interventional Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.United States
文献类型
综述
期刊
Cancers2022 Dec 29
原文标识
PubMed 36612192 · DOI 10.3390/cancers15010196